Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia

Clinical trial NCT06610266 · RECRUITING

Trial details

NCT number: NCT06610266
Sponsor: Yongquan Shi
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Gastric Intestinal Metaplasia

Start date: 2025-02-28
Primary completion: 2027-12-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.